PreferaOB One is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Alaven Pharmaceutical Llc. The primary component is Folic Acid; Heme Iron Polypeptide; Iron Dextran; Potassium Iodide; Zinc Oxide; Ascorbic Acid; Cholecalciferol; Doconexent; .alpha.-tocopherol Acetate, Dl-; Niacinamide; Pyridoxine Hydrochloride; Cyanocobalamin; Biotin; Calcium Pantothenate.
| Product ID | 68220-086_69e082a6-77dd-46e0-b3eb-90bb6d167b82 | 
| NDC | 68220-086 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | PreferaOB One | 
| Generic Name | Folic Acid, Heme Iron Polypeptide, Iron Dextran, Potassium Iodide, Zinc Oxide, Ascorbic Acid, Cholecalciferol, Doconexent, .alpha.-tocopherol Acetate, Dl-, Niacinamide, Pyridoxine Hydrochloride, Cyano | 
| Dosage Form | Capsule | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2010-04-01 | 
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER | 
| Labeler Name | Alaven Pharmaceutical LLC | 
| Substance Name | FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; POTASSIUM IODIDE; ZINC OXIDE; ASCORBIC ACID; CHOLECALCIFEROL; DOCONEXENT; .ALPHA.-TOCOPHEROL ACETATE, DL-; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; CYANOCOBALAMIN; BIOTIN; CALCIUM PANTOTHENATE | 
| Active Ingredient Strength | 1 mg/1; mg/1; mg/1; ug/1; ug/1; mg/1; [iU]/1; mg/1; [iU]/1; mg/1; mg/1; ug/1; ug/1; mg/1 | 
| Pharm Classes | Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC] | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2017-12-31 | 
| Marketing Start Date | 2010-04-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-04-01 | 
| Marketing End Date | 2019-01-01 | 
| Inactivation Date | 2019-10-21 | 
| Reactivation Date | 2020-02-04 | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-04-01 | 
| Marketing End Date | 2019-01-01 | 
| Marketing Category | Unapproved drug other | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-04-01 | 
| Marketing End Date | 2019-01-01 | 
| Inactivation Date | 2019-10-21 | 
| Reactivation Date | 2020-02-04 | 
| Ingredient | Strength | 
|---|---|
| FOLIC ACID | 1 mg/1 | 
| SPL SET ID: | db9fede8-b6d5-40a9-84cb-f928553f8e6c | 
| Manufacturer | |
| UNII | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  PREFERAOB ONE  85055113  3864658 Dead/Cancelled | Alaven Pharmaceutical LLC 2010-06-04 | 
|  PREFERAOB ONE  85055096  3864657 Dead/Cancelled | Alaven Pharmaceutical LLC 2010-06-04 | 
|  PREFERAOB ONE  85055082  3864656 Live/Registered | Alaven Pharmaceutical LLC 2010-06-04 |